Activity-dependent modifications of excitatory synapses contribute to synaptic maturation and plasticity, and are critical for learning and memory. Consequently, impairments in synapse formation or synaptic transmission are thought to be responsible for several types of mental disabilities. BRAG1 is a guanine nucleotide exchange factor for the small GTP-binding protein Arf6 that localizes to the postsynaptic density of excitatory synapses. Mutations in BRAG1 have been identified in families with X-linked intellectual disability (XLID). These mutations mapped to either the catalytic domain or an IQ-like motif; however, the pathophysiological basis of these mutations remains unknown. Here, we show that the BRAG1 IQ motif binds apo-calmodulin (CaM), and that calcium-induced CaM release triggers a reversible conformational change in human BRAG1. We demonstrate that BRAG1 activity, stimulated by activation of NMDA-sensitive glutamate receptors, depresses AMPA receptor (AMPA-R)-mediated transmission via JNK-mediated synaptic removal of GluA1-containing AMPA-Rs in rat hippocampal neurons. Importantly, a BRAG1 mutant that fails to activate Arf6 also fails to depress AMPA-R signaling, indicating that Arf6 activity is necessary for this process. Conversely, a mutation in the BRAG1 IQ-like motif that impairs CaM binding results in hyperactivation of Arf6 signaling and constitutive depression of AMPA transmission. Our findings reveal a role for BRAG1 in response to neuronal activity with possible clinical relevance to nonsyndromic XLID.
Introduction
The majority of fast excitatory synaptic transmission in the CNS is mediated by AMPA-and NMDA-type ionotropic glutamate receptors (Traynelis et al., 2010) . A key factor underlying the strength of individual excitatory synapses is the number of AMPA receptors (AMPA-Rs) at synapses, which is tightly regulated by AMPA-R trafficking. This regulated trafficking, largely mediated by NMDA-R signaling, plays a key role in both synaptic transmission and plasticity (Kerchner and Nicoll, 2008; Kessels and Malinow, 2009; Anggono and Huganir, 2012) . Both hyporegulation and hyperregulation of synaptic AMPA-R trafficking reduce the capacity of synaptic plasticity (McCormack et al., 2006) , and are thought to underlie numerous cognitive disorders, including mental retardation (Costa and Silva, 2003; Thomas and Huganir, 2004; Stornetta and Zhu, 2011) .
The ADP-ribosylation factor (Arf) proteins are a family of six small, ubiquitously expressed GTP-binding proteins (Donaldson and Jackson, 2011) . Of these, Arf6 localizes primarily to the plasma membrane/endosomal system, and is best known as a regulator of endocytic trafficking and actin cytoskeleton dynamics (D'Souza-Schorey and Chavrier, 2006; Myers and Casanova, 2008) . In hippocampal neurons, Arf6 has been shown to regulate dendritic arborization (Hernández-Deviez et al., 2002) , axonal outgrowth (Hernández-Deviez et al., 2004) , dendritic spine formation (Miyazaki et al., 2005; Choi et al., 2006) , and the assembly of clathrin/AP2 complexes at synaptic membranes (Krauss et al., 2003) . The human genome contains 15 Arf-guanine nucleotide exchange factors (GEFs), which catalyze the exchange of GDP for GTP via the evolutionarily conserved catalytic Sec7 domain (Casanova, 2007) . The brefeldin-resistant Arf-GEFs (BRAGs) comprise a subfamily of three proteins that are abundantly expressed within the postsynaptic density (PSD; Jordan et al., 2004; Peng et al., 2004; Dosemeci et al., 2007) .
BRAG2/IQSec1 has recently been shown to interact directly with the cytoplasmic domain of the AMPA-R subunit GluA2 and to regulate its synaptic activity-dependent endocytosis (Scholz et al., 2010) . In contrast, BRAG1/IQSec2 is reported to interact with NMDA-Rs, but not AMPA-Rs, through an indirect mechanism involving the synaptic scaffolding protein PSD-95 (Sakagami et al., 2008) . Recently, Shoubridge et al. (2010) identified four nonsynonymous single nucleotide polymorphisms (SNPs) in BRAG1 from families with nonsyndromic X-linked intellectual disability (XLID). Three of these SNPs led to nonconserved amino acid substitutions within the catalytic Sec7 domain, while the fourth was a nonconserved substitution within an IQ motif (Shoubridge et al., 2010) .
Here we report that BRAG1 has an integral role in synaptic transmission. We show that expression of exogenous BRAG1 in CA1 hippocampal neurons results in depression of AMPA-R-mediated synaptic transmission, in a manner dependent upon upstream NMDA-R activation. This depression is also dependent upon BRAG1 catalytic activity, indicating that it requires Arf6 activation. We show that BRAG1 binds calmodulin (CaM), and that a mutation in the IQ motif that prevents CaM binding results in constitutive (NMDA-R-independent) depression of AMPA-Rmediated transmission. Furthermore, BRAG1 appears to selectively control the trafficking of GluA1-containing AMPA-Rs by stimulating JNK signaling. Together, these results indicate that BRAG1 acts as a CaM-responsive switch to control AMPA-R signaling downstream of NMDA-R activation.
Materials and Methods
Reagents and antibodies. The reagents used in this study include ionomycin (Invitrogen I-24222), NMDA (Sigma M3262), APV (Sigma A5282), BAPTA-AM (Invitrogen B-1205), and CaM-Sepharose 4B (GE Life Sciences). Primary antibodies used were 9E10 ␣-Myc, 16B12 ␣-HA (Covance), ␣-GFP (Invitrogen), and ␣-PSD-95 (ThermoFisher Scientific). BRAG1 rabbit antiserum was raised against a peptide, corresponding to amino acids 258 -275 (CAVDSPGSQPPYRLSQLP), coupled to keyhole limpet hemocyanin as antigen.
DNA constructs. Human BRAG1 (KIAA0522) cDNA was obtained from the Kasuza DNA Research Institute. The coding sequence of BRAG1 was subcloned into pCMV3A-Myc using HindIII/XhoI. The BRAG1-E849K and BRAG1-IQ mutants were made by site-directed mutagenesis. The BRAG1-⌬N mutant was made by digesting BRAG1-WT with EcoRV/NruI, which creates an in-frame deletion of the N-terminal 213 aa. To create Cherry-tagged versions, BRAG1 was digested out of pCMV3A-Myc using HindIII/XhoI and ligated into mCherry-C2 (Clontech) using HindIII/SalI. The BRAG1-mCherry fusions were digested out of the mCherry-C2 plasmid using NheI/XbaI and ligated into pSinRep5 using XbaI to make Sindbis virus constructs.
Cell culture. HeLa cells were cultured and transfected as described previously (Santy and Casanova, 2001) . Dissociated hippocampal neuron cultures were prepared and transfected as described by (Zhang et al., 2003) . For ionomycin stimulation, HeLa cells were switched 4 -6 h post-transfection into serum-free DMEM for 16 -20 additional hours. Cells were then moved into fresh phenol red-free, serumfree DMEM (plus 25 mM HEPES for time-lapse imaging) containing either dimethylsulfoxide (DMSO) vehicle or 5 M ionomycin for 3 min.
Pulldown assays. Arf6-GTP levels were measured using a GST-GGA3 pulldown assay as described previously (Santy and Casanova, 2001) . Results are reported as mean Ϯ SEM and statistical differences were determined using the Wilcoxon matched pairs test. For CaM binding, HeLa cells transiently expressing myctagged BRAG1 constructs were lysed on ice in buffer A (150 mM NaCl, 1% Triton X-100, 50 mM Tris, protease inhibitors; pH 7.4) containing either 1 mM CaCl 2 or 1 mM EGTA, and incubated with CaM-Sepharose for 2 h. Densitometry was performed using ImageJ Software (National Institutes of Health) to quantify protein expression levels.
Immunofluorescence microscopy. HeLa cells were grown on glass coverslips, fixed, and processed for microscopy as described in (Santy and Casanova, 2001) . Fixed images were acquired using a 60ϫ objective on a Nikon Eclipse E800 microscope and a Q-Imaging Retiga CCD camera. Live cells were imaged in extracellular solution (150 mM NaCl, 10 mM HEPES, 5 mM KCl, and 30 mM glucose; pH 7.4) with or without 2 mM CaCl 2 using a 60ϫ objective on a DeltaVision deconvolution microscope (Applied Precision). For quantitation of BRAG1 condensation, NIS-Elements software (Nikon) was used to set a defined background threshold and automatically count puncta up to 2 m 2 . Hippocampal slice cultures. Cultured rat hippocampal slices were prepared from postnatal 6-to 7-d-old rats of either sex, infected with Sindbis virus after 7-14 d in vitro (DIV) to deliver recombinant proteins into CA1 pyramidal neurons as described previously McCormack et al., 2006) . Hippocampal extracts were prepared by homogenizing hippocampal CA1 regions isolated from cultured slices (Zhu et al., 2000 (Zhu et al., , 2002 , Viral expression efficacy of recombinant proteins in these experiments was high (Ͼ95% of CA1 neurons). Homogenizing solution contained the following (in mM or percentage): 10 HEPES, 150 NaCl, 10 EDTA, 4 EGTA, 0.2 PMSF, 0.1 NaPPi, 0.5 NaF, 1 Na 3 VO 4 , and Triton 1%. Membranes were blotted with anti-phospho-JNK (1:2000; Cell Signaling Technology) and anti-phospho-p38 MAPK antibody (1: 2000;Cell Signaling Technology), stripped and reblotted with anti-JNK (1:2000;Cell Signaling Technology) and anti-p38 MAPK antibody (1: 1000;Cell Signaling Technology). Western blots were quantified by chemiluminescence and densitometric scanning of the films under linear exposure conditions. The dendritic and spine expression of mCherry-BRAG1 was imaged with a custom-made two-photon laser scanning microscope (Zhu et al., 2000; Kolleker et al., 2003) .
Electrophysiology. Simultaneous whole-cell recordings were obtained from nearby infected and noninfected neuron pairs, under visual guidance using fluorescence and transmitted light illumination with two Axopatch-200B amplifiers (Molecular Devices) as previously described Qin et al., 2005; McCormack et al., 2006; Zhu, 2009) . Cultured rat organotypic slices exhibit relatively high spontaneous activity comparable to intact brains. Thus, high calcium and magnesium bath solution (29 Ϯ 1.5°C), containing the following (in mM): 119 NaCl, 2.5 KCl, 4 CaCl 2 , 4 MgCl 2 , 26 NaHCO 3 , 1 NaH 2 PO 4 , 11 glucose, 0.1 picrotoxin, and 0.002 2-chloroadenosine, pH 7.4, was used to prevent epileptic activity after blocking inhibition. The bath solutions were gassed with 5% CO 2 / 95% O 2 . Patch recording pipettes (3-6 M⍀) contained the following (in mM): 115 cesium methanesulfonate, 20 CsCl, 10 HEPES, 2.5 MgCl 2 , 4 Na 2 ATP, 0.4 Na 3 GTP, 10 sodium phosphocreatine, 0.6 EGTA, and 0.1 spermine, at pH 7.25. Synaptic responses were evoked by bipolar electrodes with single voltage pulses (200 s, up to 20 V) placed in hippocampal stratum radiatum ϳ300 m away from the recorded hippocampal CA1 pyramidal neurons. To minimize the effect from AMPA responses, the peak NMDA responses at ϩ40 mV were measured after digital subtraction of estimated AMPA responses at ϩ40 mV. Results are reported as mean Ϯ SEM and statistical differences were determined using Wilcoxon test.
Results

BRAG1 interaction with CaM
IQ motifs are best known as binding domains for CaM. Although BRAG1, BRAG2, and BRAG3 each contain an IQ-like motif N terminal to the catalytic domain (Fig. 1A) , it has not yet been demonstrated that any of the BRAGs do indeed bind CaM. Inspection of this motif (residues 354 -363) indicated that it fits the consensus sequence for calcium-independent CaM binding ( Fig.  1 B) (Rhoads and Friedberg, 1997) . To determine whether this is the case, lysates of HeLa cells expressing Myc-tagged BRAG1 were incubated with CaM-Sepharose in either the presence or absence of Ca 2ϩ (2 mM CaCl 2 or 2 mM EGTA, respectively). As shown in Figure 1C , BRAG1 was robustly precipitated by CaM-Sepharose, but not Sepharose alone. Moreover, this interaction was strengthened in the presence of EGTA, indicating that BRAG1 preferentially binds to Ca 2ϩ -free CaM. Substitution of three conserved residues within the consensus IQ motif (I 354 QTAFR to AATAFA, hereafter referred to as BRAG1-IQ) completely abrogated CaM binding (Fig. 1C) . However, mutation of a conserved glutamate residue within the Sec7 domain essential for catalytic activity (E849K, hereafter referred to as BRAG1-EK) (Shoubridge et al., 2010) , had no effect on the ability of BRAG1 to bind CaM, indicating that catalytic activity does not impact CaM binding (Fig. 1C) . Deletion of an N-terminal coiled-coil domain (BRAG1-⌬N) does appear to result in more efficient CaM binding than BRAG1-WT. This may be a result of the enhanced solubility of BRAG1-⌬N (see below), or it could suggest that the coiled-coil motif regulates accessibility of the IQ motif to CaM.
BRAG1 localization to the PSD
Previous studies have revealed the localization of BRAG1 specifically at the postsynaptic membrane of excitatory synapses using both immunofluorescence and electron microscopy (Murphy et al., 2006; Sakagami et al., 2008) . To confirm this localization, we stained dissociated rat hippocampal neurons at 21 DIV with rab- Note that BRAG1-IQ is punctate in the absence of ionomycin and does not change its distribution after ionomycin addition. C, Calcium-induced condensation of BRAG1 is reversible. HeLa cells were either left untreated (left), were treated with 5 M ionomycin for 3 min (center), or were treated with 5 M ionomycin for 3 min followed by incubation with 5 mM BAPTA-AM for 10 min (right). D, BRAG1-⌬N does not form puncta in response to ionomycin stimulation. Cells expressing mCherry-BRAG1-⌬N were treated with ionomycin for 3 min and imaged as described above. E, Quantification of calcium-induced puncta formation. Cells expressing BRAG1-WT, BRAG1-IQ or BRAG1-⌬N were treated with either vehicle (DMSO) or ionomycin for 3 min, then fixed and imaged. Puncta were quantified as described previously (see Materials and Methods) from at least 18 cells from three independent experiments. Mean number of BRAG1 puncta per 100 m 2 pre-and post-ionomycin stimulation (WT-pre: 4.6 Ϯ 0.9 puncta, n ϭ 19; WT-post: 66.6 Ϯ 13.5 puncta; n ϭ 19, p Ͻ 0.001; IQ-pre: 67.5 Ϯ 7.4 puncta, n ϭ 17; IQ-post: 76.6 Ϯ 19.5 puncta; n ϭ 17, p ϭ 0.25; ⌬N-pre: 0.0 Ϯ 0. puncta, n ϭ 18; ⌬N-post: 13.8 Ϯ 3.8 puncta; n ϭ 19, p Ͻ 0.005). *p Յ 0.005 (Student's t test). F, The N terminus of BRAG1 is necessary for self-association. Myc-BRAG1-WT or myc-BRAG1-⌬N were coexpressed in HeLa cells with GFP-BRAG1 WT. Cell lysates were then immunoprecipitated with anti-GFP, and the presence of bound myc-BRAG1 detected by immunoblotting with anti-myc. Scale bars: 10 m. bit antiserum raised against a peptide corresponding to amino acids 258 -275 of BRAG1. As expected from previous studies, we detected endogenous BRAG1 at discrete clusters along dendrites that clearly colabel with the excitatory postsynaptic marker, PSD-95 (Fig. 2 A) . We next sought to confirm that exogenously expressed mCherry-tagged BRAG1 fusion proteins localized to excitatory synapses, similar to endogenous BRAG1. Therefore, we transfected dissociated rat hippocampal neurons at DIV 6 with wild-type BRAG1 fused to mCherry at its N terminus. Neurons were fixed at DIV 21 and counterstained for PSD-95. In contrast to soluble mCherry, which is diffusely distributed and fails to localize to any particular compartment (Fig. 2 B) , mCherry-BRAG1 was found in prominent puncta distributed along the length of dendrites, where it clearly colocalized with PSD-95 (Fig. 2C) .
BRAG1-EK colocalized with PSD-95 to the same extent as BRAG1-WT, indicating that catalytic activity does not direct or alter BRAG1 localization. We also examined whether the IQ motif of BRAG1 was required for its localization to the PSD. Although the majority of cherry-tagged BRAG1-IQ was localized to the PSD (Fig. 2 E) , we detected the presence of puncta within the shaft of the dendrite that were not observed in cells expressing either BRAG1-WT or BRAG1-EK. The BRAG1-⌬N mutant, which lacks the N-terminal coiled-coil motif, also colocalizes with PSD-95 at synapses. However, we also observed a significant fraction of BRAG1-⌬N diffusely distributed throughout the dendritic shaft (Fig. 2 F) . In summary, these results suggest that neither catalytic activity nor an intact IQ motif or coiled-coil domain is necessary for the localization of BRAG1 to the PSD.
The IQ motif regulates a calcium-dependent conformational switch in BRAG1
The calcium-dependent release of CaM from BRAG1 suggests that changes in intracellular calcium levels may regulate the BRAG1-CaM interaction, and that this might modulate BRAG1 conformation or activity. To test this idea, we examined the effects of calcium influx on mCherry-BRAG1 distribution in live HeLa cells stimulated with the calcium ionophore, ionomycin. As shown in Figure 3A , BRAG1 is mostly diffuse at steady state. However, within 30 s of ionomycin treatment, we observed the formation of discrete BRAG1 puncta scattered throughout the cell (Fig. 3A) . These appear to be aggregates of protein, as they do not contain endosomal or other intracellular membranes (data not shown). In contrast, BRAG1-IQ exhibited a punctate distribution even in the absence of ionomycin, and did not undergo a change in its localization upon Ca 2ϩ influx (Fig. 3B ). These observations suggest that the Ca 2ϩ -induced release of CaM triggers a conformational change in BRAG1, manifested in HeLa cells as condensation into cytoplasmic puncta.
This conformational change is completely reversible, as treatment with the cell-permeable calcium chelator BAPTA-AM resulted in nearly complete dissolution of the ionomycin-induced puncta. This indicates that the redistribution of BRAG1 upon calcium influx is not simply due to protein degradation or denaturation, and likely involves a regulated change in BRAG1 conformation. Quantitation of this phenomenon indicated an ϳ15-fold increase in the number of BRAG1-WT puncta after ionomycin treatment, which was statistically indistinguishable from BRAG1-IQ in the absence of ionomycin (Fig. 3D) .
The N terminus of BRAG1 mediates calcium-dependent self-association Because coiled-coil domains commonly mediate homooligomerization or protein-protein interactions (Burkhard et al., 2001) , we speculated that the N-terminal BRAG1 coiled-coil domain (residues 23-74) plays a role in its calcium-induced selfassociation. Deletion of this domain (BRAG1-⌬N) did not affect the steady-state distribution of BRAG1 in HeLa cells (Fig. 3E) . However, unlike wild-type BRAG1, BRAG1-⌬N remained diffusely cytosolic upon addition of ionomycin (Fig. 3E ). This observation indicates that Ca 2ϩ -induced self-association of wild-type BRAG1 is dependent upon the N-terminal coiledcoil domain.
To support this hypothesis, we tested the ability of BRAG1 to oligomerize. For this purpose, GFP-tagged BRAG1-WT was expressed in HeLa cells along with either myc-tagged BRAG1-WT or myc-BRAG1-⌬N. When GFP-BRAG1-WT was immunoprecipitated with anti-GFP antibody, we found that myc-BRAG1-WT coprecipitated efficiently while myc-BRAG1-⌬N did not (Fig.  3F ). This observation indicates that BRAG1 can oligomerize via its N-terminal coiled-coil domain, and suggests that regulated oligomerization, induced by CaM release, may have an important role in BRAG1 function in the synapse.
An influx of extracellular calcium is known to occur upon activation of NMDA-Rs. To determine whether BRAG1 responds to physiological levels of calcium in the neuronal context, we expressed mCherry-tagged BRAG1-WT in cultured hippocampal neurons and followed its localization after NMDA stimulation using live cell imaging (Fig. 4 A) . Before stimulation, BRAG1-WT was stably localized to the PSD. However, after the addition of 30 M NMDA, small BRAG1 puncta appeared within spines and within the dendritic shaft, in addition to its normal synaptic localization. These smaller puncta were reminiscent of those seen in HeLa cells after ionomycin stimulation, and are consistent with the idea of calcium-induced self-association of BRAG1. We also examined the effects of NMDA stimulation on the distribution of BRAG1-IQ and BRAG1-⌬N in hippocampal neurons (Fig. 4 B, C) . Similar to our findings in HeLa cells treated with ionomycin, we saw no detectable changes in the distribution of either mutant after NMDA stimulation (Fig. 4 D) . This suggested that the NMDA-induced condensation of BRAG1 in hippocampal neurons requires both the IQ and the coiled-coil motifs.
CaM binding is not required for BRAG1 catalytic activity
To test whether the IQ domain or the N terminal coiled-coil domain regulates BRAG1 Arf-GEF activity, we measured their . BRAG1-WT and BRAG1 mutants differentially affect synaptic transmission. A, Evoked AMPA-R-mediated (Ϫ60 mV) and NMDA-R-mediated (ϩ40 mV) responses recorded from neighboring nonexpressing (Ctrl) and mCherry-tagged BRAG1-WT-or BRAG1-⌬N-expressing neurons cultured in normal media or media containing 100 M DL-APV. B, Values for AMPA responses in neurons expressing BRAG1-WT and BRAG1-⌬N cultured in normal media (Ctrl: Ϫ31.6 Ϯ 2.5 pA; WT: Ϫ22.9 Ϯ 2.4 pA; n ϭ 38; p Ͻ 0.05; Ctrl: Ϫ14.2 Ϯ 2.1 pA; ⌬N: Ϫ20.1 Ϯ 3.2 pA; n ϭ 16; p Ͻ 0.05), in media containing high Mg 2ϩ (Ctrl: Ϫ26.8 Ϯ 2.6 pA; WT: Ϫ28.8 Ϯ 3.1 pA; n ϭ 22; p ϭ 0.94; Ctrl: Ϫ20.3 Ϯ 1.7 pA; ⌬N: Ϫ21.4 Ϯ 2.3 pA; n ϭ 23; p ϭ 0.93), or in media containing DL-APV (Ctrl: Ϫ31. ability to activate Arf6 in HeLa cells using a previously described GST-GGA3 pulldown assay (Santy and Casanova, 2001 ) to specifically precipitate GTPbound Arf6. Coexpression of BRAG1-WT with Arf6 in HeLa cells enhanced Arf6 activation fourfold relative to cells expressing Arf6 alone (Fig. 5 A, B) . As expected, the catalytically inactive mutant BRAG1-E849K failed to activate Arf6 above basal levels. Surprisingly, both BRAG1-IQ and BRAG1-⌬N mutants significantly stimulated Arf6 activity, although the BRAG1-⌬N-mediated activity was slightly lower than BRAG1-WT.
Activation of BRAG1 depresses AMPA-R-mediated transmission in CA1 neurons
To further examine the synaptic functions of BRAG1, we used recombinant Sindbis virus to acutely overexpress mCherry-BRAG1 in CA1 pyramidal neurons of rat hippocampal cultured slices. In expressing neurons, mCherry-BRAG1 was diffusely distributed and infiltrated in dendritic spines, the sites of excitatory synapses (Fig. 6 A) . Electrophysiological recordings were obtained simultaneously from nearby expressing and nonexpressing neurons. We found that expression of mCherry-BRAG1 had no effects on basic membrane properties, including resting membrane potentials, input resistance, and membrane time constants (Fig. 6 B, C) . We then examined EPSCs in expressing neurons and nearby control nonexpressing neurons by stimulating the afferent fibers. Neurons expressing wild-type BRAG1 exhibited depressed (by ϳ30%) AMPA-R-mediated responses compared with nearby nonexpressing controls (Fig. 7 A, B) , suggesting that activating BRAG1 depresses transmission. Interestingly, expression of BRAG1-⌬N did not suppress AMPA-R activity, but instead potentiated it (Fig.  7A,B) , suggesting a possible dominant-negative effect. No significant difference was observed in NMDA-R-mediated responses between BRAG1-expressing and nonexpressing neurons (Fig. 7A,B) , suggesting a postsynaptic mechanism.
To determine whether BRAG1 signaling is stimulated by synaptic and NMDA-R activity, we included 12 mM MgCl 2 , which depresses synaptic transmission (Zhu et al., 2000) , or DL-APV, a pharmacological blocker of NMDA-Rs, in culture media during expression of BRAG1. Both high Mg 2ϩ and APV completely blocked the effects of both BRAG1-WT and BRAG1-⌬N expression on AMPA synaptic transmission (Fig. 7 A, B) . These results indicate that spontaneous synaptic activity activates NMDA-Rs that in turn activate BRAG1, producing a tonic depression of AMPA-R-mediated transmission.
To examine how mutations in the catalytic or IQ domains might affect synaptic transmission, we expressed mCherrytagged BRAG1-EK or BRAG1-IQ in CA1 neurons. In contrast to wild-type BRAG1, which depressed AMPA responses, neurons expressing the catalytically inactive BRAG1-EK mutant responded similarly to controls, indicating that BRAG1 catalytic activity is necessary for the observed depression observed upon expression of the wild-type protein (Fig. 7C,D) . The IQ domain mutant reduced AMPA responses to a similar extent as the wildtype protein, consistent with its retention of catalytic activity (Fig.  7C,D) . However unlike BRAG1-WT, which is entirely dependent upon NMDA-R signaling, the depressive effect of BRAG1-IQ was not blocked by high Mg 2ϩ or APV. This observation suggests that the inability to interact with CaM abrogates the requirement for NMDA-R activation, and renders this mutant constitutively active.
BRAG1-Arf6 stimulates JNK-mediated synaptic GluA1 removal in CA1 neurons
To determine how BRAG1 depresses synaptic transmission, we examined whether BRAG1 mutants affect endogenous Arf6 signaling in CA1 neurons in hippocampal cultured slices using the GST-GGA3 pulldown assay (Santy and Casanova, 2001) . As shown in Figure 8 , CA1 cells expressing BRAG1-IQ displayed increased levels of active Arf6-GTP, whereas those expressing BRAG1-⌬N had decreased levels of active Arf6-GTP compared with control nonexpressing CA1 cells, indicating that BRAG1-IQ stimulates and BRAG1-⌬N inhibits endogenous Arf6 activity in neurons.
We then investigated whether BRAG1-Arf6 signals synaptic depression by stimulating the JNK and p38 MAPK signaling pathways, which depress transmission by stimulating synaptic removal of AMPA-Rs (Zhu et al., 2002 Kielland et al., 2009) . To test this idea, we included SP600125, an inhibitor of JNK (Bennett et al., 2001) , or SB203580, which inhibits p38 MAPK (Lee et al., 1999) , in culture media during expression of BRAG1-IQ and BRAG1-⌬N. SP600125, but not SB203580, completely blocked the depressive effect of BRAG1-IQ and the potentiative effect of BRAG1-⌬N in CA1 neurons (Fig. 9 A, B) , suggesting a selective involvement of JNK signaling. Consistent with this idea, Western blots showed that expression of BRAG1-IQ increased levels of phosphorylated JNK in CA1 cells, while expression of BRAG1-⌬N decreased JNK activation (Fig.  9C,D) . Importantly, neither construct affected the levels of p38 MAPK phosphorylation (Fig. 9C,D) . Expression of BRAG1-IQ or BRAG1-⌬N did not alter the levels of total JNK and p38 (Fig.  9C,D) . Collectively, these results indicate that BRAG1-Arf6 signals synaptic depression via stimulating JNK signaling, but not p38 MAPK signaling.
JNK and p38MAPK depress transmission by signaling synaptic removal of GluA1-and GluA2-containing AMPA-Rs, respectively (Zhu et al., 2002 Kielland et al., 2009 ). To test whether BRAG1-Arf6 regulates synaptic trafficking of GluA1-and/or GluA2-containg AMPA-Rs, we examined the effects of Figure 8 . BRAG1 regulates endogenous Arf6 signaling. A, Relative levels of GTP-bound Arf6 and total Arf6 in control hippocampal CA1 regions, and hippocampal CA1 regions expressing BRAG1-IQ or BRAG1-⌬N cultured in normal media. For each set of hippocampal CA1 cell lysate, 35 g protein was used to precipitate and blot GTP-bound Arf6 and 7.5 g protein was used to directly blot total Arf6. B, Relative amounts of Arf6-GTP (Ctrl: 100.0 Ϯ 6.5%; IQ: 120.9 Ϯ 6.3%; n ϭ 22; p Ͻ 0.005; ⌬N: 87.1 Ϯ 7.7%; n ϭ 22; p Ͻ 0.05) and total Arf6 (Ctrl: 100.0 Ϯ 7.1%; IQ: 90.7 Ϯ 7.5%; n ϭ 22; p ϭ 0.21; ⌬N: 100.6 Ϯ 9.6%; n ϭ 22; p ϭ 0.86) in control hippocampal CA1 regions, and hippocampal CA1 regions expressing BRAG1-IQ or BRAG1-⌬N. The relative values and SEs were normalized to average amounts of Arf6-GTP or total Arf6 from control untreated cells. *p Ͻ 0.05 (Wilcoxon test).
BRAG1 mutants in CA1 neurons prepared from GluA1 and GluA2 knock-out mice. As shown in Figure 10 , the depressive effect of BRAG1-IQ and potentiative effect of BRAG1-⌬N were occluded or blocked in GluA1 but not GluA2 knock-out CA1 neurons. These results suggest that BRAG1-Arf6 signals synaptic depression via stimulating JNK-mediated synaptic removal of GluA1-containing AMPA-Rs.
Discussion
The Arf GEFs BRAG1, BRAG2, and BRAG3 are highly enriched in the brain, where they are concentrated in postsynaptic densities. While all three BRAG family proteins are expressed in hippocampal neurons, BRAG3 localizes specifically to the PSDs of inhibitory synapses, whereas both BRAG1 and BRAG2 are found at excitatory synapses (Sakagami et al., 2008; Scholz et al., 2010; Fukaya et al., 2011) . While BRAG2 was recently shown to regulate mGluR-dependent synaptic removal of GluA2-containing AMPA-Rs (Scholz et al., 2010) , the synaptic function of BRAG1, which is implicated in nonsyndromic XLID (Shoubridge et al., 2010) , had not been investigated. Here we report that BRAG1 signals synaptic depression of AMPA transmission in response to synaptic activation of NMDA-Rs. We further show that diseaseassociated mutations, which affect either catalytic activity or CaM binding, result in either inhibition or constitutive activation of Arf6 signaling, respectively. Moreover, while BRAG2 acts on GluA2-containing AMPA-Rs (Scholz et al., 2010) , BRAG1 appears to selectively modulate GluA1-containing AMPA-Rmediated transmission through a mechanism that involves the downstream activation of JNK. These observations provide new insight into the machinery controlling AMPA-R trafficking, and provide a mechanistic basis for the defects in learning and memory exhibited by patients with XLID.
Mechanisms of BRAG1-Arf6 signaling
Synaptic NMDA-R activation induces a rapid local increase in Ca 2ϩ levels that is critical for the induction of synaptic plasticity (Malenka et al., 1988) . The IQ motif is evolutionarily conserved among the BRAG family Arf-GEFs, and although it has been assumed to bind CaM, this had not been previously demonstrated. Here we provide the first evidence that the BRAG1 IQ motif does indeed bind CaM, and that it preferentially interacts with the Ca 2ϩ -free form. We also show that CaM dissociation triggered by Ca 2ϩ influx induces a conformational change in BRAG1 resulting in a change in subcellular distribution. However, while CaM binding clearly impacts conformation, its relationship to BRAG1 function is complex. In heterologous cells, ; IQ: 118.9 Ϯ 7.5%; n ϭ 12; p Ͻ 0.005; ⌬N: 89.6 Ϯ 5.8%; n ϭ 12; p Ͻ 0.01) and phospho-p54 (Ctrl: 100.0 Ϯ 11.0%; IQ: 117.4 Ϯ 11.6%; n ϭ 12; p Ͻ 0.005; ⌬N: 81.6 Ϯ 9.9%; n ϭ 12; p Ͻ 0.005) JNK in hippocampal CA1 regions expressing BRAG1-IQ and BRAG1-⌬N. Relative amounts of total p46 (Ctrl: 100.0 Ϯ 7.7%; IQ: 101.2 Ϯ 8.2%; n ϭ 12; p ϭ 0.64; ⌬N: 98.3 Ϯ 8.1%; n ϭ 12; p ϭ 0.43) and total p54 (Ctrl: 100.0 Ϯ 10.2%; IQ: 107.2 Ϯ 11.0%; n ϭ 12; p ϭ 0.14; ⌬N: 101.3 Ϯ 10.2%; n ϭ 12; p ϭ 0.24) JNK in hippocampal CA1 regions expressing BRAG1-IQ and BRAG1-⌬N. Right, Relative amounts of phospho-p38 MAPK (Ctrl: 100.0 Ϯ 9.1%; IQ: 105.1 Ϯ 9.5%; n ϭ 12; p ϭ 0.31; ⌬N: 107.9 Ϯ 8.7%; n ϭ 12; p ϭ 0.11) in hippocampal CA1 regions expressing BRAG1-IQ and BRAG1-⌬N. Relative amounts of total p38 MAPK (Ctrl: 100.0 Ϯ 9.9%; IQ: 103.0 Ϯ 10.8%; n ϭ 12; p ϭ 0.64; ⌬N: 106.0 Ϯ 10.7%; n ϭ 12; p ϭ 0.94) in hippocampal CA1 regions expressing BRAG1-IQ and BRAG1-⌬N. The relative values and SEs were normalized to average amounts of AMPA and NMDA responses from control CA1 cells, phospho-JNK, phospho-p38 MAPK, total JNK, or total p38 MAPK from control hippocampal CA1 regions. *p Ͻ 0.05 (Wilcoxon test).
BRAG1 catalytic activity appears to be constitutive and is not affected by mutations in the IQ motif that abrogate CaM binding. Similarly, disruption of the catalytic domain, but not the IQ motif, of the single Drosophila BRAG gene Loner was found to cause defects in myoblast fusion (Chen et al., 2003) . However, our results show that in hippocampal neurons BRAG1 activity is tightly regulated, requiring upstream NMDA-R activity. Mutation of the IQ motif relieves this constraint, allowing AMPA-R downregulation in the absence of NMDA-R activity. These observations suggest a model in which NMDA-R-mediated Ca 2ϩ influx triggers the release of CaM from BRAG1, which then stimulates AMPA-R endocytosis via its activation of Arf6 (Fig. 11) . They also provide a mechanistic explanation for how mutation of the IQ motif found in one family with XLID may cause disease: failure to bind CaM leads to constitutive BRAG1 activity, resulting in chronic downregulation of AMPA-R signaling.
The responsiveness of BRAG1 to Ca 2ϩ in the neuronal context is presumably due to the presence of neuron-specific binding partners that help anchor it in the PSD or mediate interactions with other proteins involved in AMPA-R trafficking. In this regard it is interesting that a BRAG1 mutant lacking the N-terminal coiled-coil domain actually potentiates AMPA responses, suggesting that it acts as a dominant-negative to inhibit the function of endogenous BRAG1. This hypothesis is supported by the observation that both endogenous Arf6 activity and JNK activity are reduced in the presence of BRAG1-⌬N. Because BRAG1-⌬N is more diffusely distributed within the dendritic shaft and spines, it may bind and sequester components that are limiting for receptor internalization, JNK activation, or both.
Signaling interaction of BRAG1-Arf6 and Rap2-JNK-PP2B
In this study, we provide the first evidence that BRAG1-Arf6 signaling intersects the Rap2-MINK-JNK-PP2B signaling pathway at synapses. Previous studies have shown that synaptic activation of NMDA-Rs increases Rap2 signaling, which controls dephosphorylation and synaptic removal of GluA1-containing AMPA-Rs during depotentiation via stimulating the MINK-JNK-PP2B signaling pathway Kielland et al., 2009; Hussain et al., 2010; Yang et al., 2011) . We show here that synaptic activity also stimulates BRAG1-Arf6 activity. Interestingly, activation of BRAG1-Arf6 depresses synaptic transmission via stimulating JNK, and blocking JNK activity blocks BRAG1-Arf6-mediated synaptic depression. These results are consistent with previous observations that Arf6 can signal downstream via a neuronal scaffolding protein JIP3 (Montagnac et al., 2009; Suzuki et al., 2010) , and that JIP3 regulates JNK signaling (Kelkar et al., 2000; Ongusaha et al., 2008) . Moreover, the BRAG1-mediated synaptic depression, which requires Arf6 activation, is mediated by synaptic trafficking of GluA1-containing AMPA-Rs. Together, these results suggest that BRAG1-Arf6 depresses synaptic transmission via regulating Rap2-JNK-PP2B signaling.
Altered BRAG1 signaling in X-linked mental disability
Our results suggest a novel synaptic signaling mechanism whose dysregulation results in X-linked mental retardation. Previous stud- Figure 10 . BRAG1 signaling regulates synaptic trafficking of GluA1-containing AMPA-Rs. A, Evoked AMPA-R-mediated (Ϫ60 mV) and NMDA-R-mediated (ϩ40 mV) responses recorded from neighboring nonexpressing (Ctrl) and mCherry-tagged BRAG1-IQ or BRAG1-⌬N expressing neurons prepared from GluA1 or GluA2 knock-out mice. B, Values for AMPA responses in BRAG1-IQ and BRAG1-⌬N expressing neurons prepared from GluA1 (Ctrl: Ϫ23.5 Ϯ 1.8 pA; IQ: Ϫ24.1 Ϯ 2.0 pA; n ϭ 20, p ϭ 0.88; Ctrl: Ϫ26.2 Ϯ 2.5 pA; ⌬N: Ϫ26.2 Ϯ 1.5 pA; n ϭ 20, p ϭ 0.82) or GluA2 (Ctrl: Ϫ30.9 Ϯ 2.1 pA; IQ: Ϫ20.9 Ϯ 1.6 pA; n ϭ 20, p Ͻ 0.005; Ctrl: Ϫ24.5 Ϯ 1.7 pA; ⌬N: Ϫ31.5 Ϯ 2.9 pA; n ϭ 24, p Ͻ 0.005) knock-out mice, and for NMDA responses in BRAG1-IQ and BRAG1-⌬N expressing neurons prepared from GluA1 (Ctrl: 94.9 Ϯ 7.6 pA; IQ: 91.9 Ϯ 8.4 pA; n ϭ 20, p ϭ 0.91; Ctrl: 113.6 Ϯ 8.7 pA; ⌬N: 111.9 Ϯ 9.8 pA; n ϭ 20, p ϭ 0.97) or GluA2 (Ctrl: 54.5 Ϯ 5.0 pA; IQ: 54.8 Ϯ 5.2 pA; n ϭ 20, p ϭ 0.46; Ctrl: 60.1 Ϯ 5.2 pA; ⌬N: 61.8 Ϯ 4.4 pA; n ϭ 24, p ϭ 0.63) knock-out mice. The relative values and SEs were normalized to average amounts of AMPA and NMDA responses from control CA1 cells. *p Ͻ 0.05 (Wilcoxon test). Figure 11 . Model for BRAG1-mediated synaptic trafficking of GluA1-containing AMPA-Rs. BRAG1 is anchored at PSDs via its interaction with PSD-95, which also interacts with NMDA receptors. Calcium influx triggered by NMDAR activation causes CaM release from BRAG1, which causes a conformational change leading to enhanced catalytic activity. BRAG1 activates Arf6 which, through downstream activation of JNK, triggers internalization of GluA1-containing AMPA receptors.
ies have examined the signaling and synaptic mechanisms for two other X-linked mental disorders, oligophrenin-1-associated X-linked mental retardation and fragile X syndrome. Loss of function of oligophrenin-1 is believed to be responsible for the cognitive impairment associated with X-linked mental retardation (Billuart et al., 1998) , and recent evidence shows that oligophrenin-1 signals synaptic removal of GluA2-containing AMPA-Rs in a synaptic activity-dependent manner (Nadif Kasri et al., 2009 Kasri et al., , 2011 . In FMR1 knock-out mice, a mouse model for fragile X syndrome (DutchBelgian Fragile X Consortium, 1994), mGluA-dependent LTD is modestly upregulated by ϳ10 -15%, whereas NMDA-R-dependent LTP is considerably reduced (by ϳ50%) in the knock-out animals (Pfeiffer and Huber, 2009; Stornetta and Zhu, 2011) . The increased mGluA-dependent LTD is mediated by enhanced Arc signaling (Waung et al., 2008) , which controls p38 MAPK-mediated synaptic removal of GluA2-containing AMPA-Rs (Bolshakov et al., 2000; Rial Verde et al., 2006) . Exaggerated mGluR signaling seems responsible for several syndromic features of fragile X, including the altered ocular dominance plasticity, seizure, and passive avoidance (Krueger and Bear, 2011) . The defect in long-term potentiation (LTP) is due to the selective impairment of signal transduction between Ras and PI3K that abolishes synaptic delivery of GluA1-containing AMPA-Rs (Hu et al., 2008) . This deficient LTP is responsible for the impaired active, high-level associative learning associated with fragile X (Zhao et al., 2005; Hayashi et al., 2007) , which is consistent with the finding that synaptic trafficking of GluA1-containing AMPA-Rs is essential for experience-dependent synaptic plasticity and associative learning Rumpel et al., 2005; McCormack et al., 2006; Hu et al., 2007; Matsuo et al., 2008; Kielland et al., 2009; Zhu, 2009) . Here, we report that BRAG1-Arf6 regulates the JNK-mediated synaptic removal of GluA1-containing AMPA-Rs (Fig. 11) . Moreover, BRAG1 mutations associated with nonsyndromic X-linked mental retardation impair both JNK signaling and synaptic trafficking of GluA1-, but not GluA2-containing AMPA-Rs. These results thus provide the first evidence that dysregulation of JNK signaling and synaptic removal of GluA1-containing AMPA-Rs may also lead to X-linked mental retardation, and provide a new mechanistic explanation for how mutations that either inhibit or enhance Arf6 activity may all result in nonsyndromic X-linked mental disability.
